The burden of chronic hepatitis B virus infection in Australia, 2011

Australian and New Zealand Journal of Public Health

Volumn 37, Issue 5, 2013, Pages 416-422

  Maclachlan, Jennifer H ^a,c   Allard, Nicole ^a,c   Towell, Vanessa ^b   Cowie, Benjamin C ^a,c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b Australasian Society for HIV Medicine   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

epidemiology; hepatitis B; liver cancer; public health; viral hepatitis

Indexed keywords

AUSTRALIA; COST OF ILLNESS; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HEPATITIS B, CHRONIC; HOMOSEXUALITY; HUMAN; MALE; MIDDLE AGED; MIGRATION; OCEANIC ANCESTRY GROUP; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; SICKNESS IMPACT PROFILE; STATISTICS AND NUMERICAL DATA; ABORIGINE; ARTICLE; HEPATITIS B; LIVER CANCER; STATISTICS; VIRUS HEPATITIS;

AUSTRALIA; COST OF ILLNESS; FEMALE; HEPATITIS B, CHRONIC; HOMOSEXUALITY; HUMANS; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; POPULATION SURVEILLANCE; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; SICKNESS IMPACT PROFILE; TRANSIENTS AND MIGRANTS;

EPIDEMIOLOGY; HEPATITIS B; LIVER CANCER; PUBLIC HEALTH; VIRAL HEPATITIS;

EID: 84880704432     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/1753-6405.12049     Document Type: Article

References (37)

1. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ,. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004; 28 (3): 212-16.
2. Department of Health and Ageing. National Hepatitis B Strategy 2010-2013. Canberra (AUST): Commonwealth of Australia; 2010 April 22.
3. Office of Health Protection. The Australian Immunisation Handbook. 9th ed. Canberra (AUST): Commonwealth Department of Health and Ageing; 2008.
4. Cowie BC,. Is it even more cost effective for well resourced, low hepatitis B prevalence countries to vaccinate infants in endemic regions than their own children? J Hepatol. 2011; 54 Suppl 1: S146.
5. MacLachlan JH, Cowie BC,. Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust. 2012; 197 (9): 492-3.
6. Nguyen VT, Razali K, Amin J, Law MG, Dore GJ,. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol. 2008; 23 (6): 922-9.
7. Australian Bureau of Statistics. 2006 Census of Population and Housing. Canberra (AUST): ABS; 2007.
8. Australian Bureau of Statistics. 2011 Census of Population and Housing. Canberra (AUST): ABS; 2012.
9. Department of Immigration and Citizenship. Trends in Migration: Australia 2010-11. Canberra (AUST): Commonwealth of Australia; 2012.
10. Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al,. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007; 25 (51): 8637-41.
11. Smith AM, Rissel CE, Richters J, Grulich AE, de Visser RO,. Sex in Australia: sexual identity, sexual attraction and sexual experience among a representative sample of adults. Aust N Z J Public Health. 2003; 27 (2): 138-45.
12. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Drug Statistics Series No.: 25. Catalogue No.: PHE 145. Canberra (AUST): AIHW; 2011.
13. Turnour CE, Cretikos MA, Conaty SJ,. Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data. Aust N Z J Public Health. 2011; 35 (1): 22-6.
14. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL,. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012; 56 (2): 422-33.
15. Anderson B, Bodsworth NJ, Rohrsheim RA, Donovan BJ,. Hepatitis B virus infection and vaccination status of high risk people in Sydney: 1982 and 1991. Med J Aust. 1994; 161 (6): 368-71.
16. Burrell CJ, Cameron AS, Hart G, Melbourne J, Beal RW,. Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and crossinfection policies. Med J Aust. 1983; 2 (10): 492-6.
17. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al,. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378 (9791): 571-83.
18. Richards M, Lucas CR, Gust I,. Hepatitis in male homosexuals in Melbourne. Med J Aust. 1983; 2 (10): 474-5.
19. Graham S, Guy R, Akre S, Cowie B, Ward J,. Hepatitis B among Aboriginal and Torres Strait Islander People-Key Sub-groups. Proceedings of the Australasian Sexual Health Conference; 2011 Sep 26-30; Canberra, Aust. Canberra: Australasion Society for HIV Medicine; 2011.
20. Schultz R, Romanes F, Krause V,. Hepatitis B prevalence and prevention: antenatal screening and protection of infants at risk in the Northern Territory. Aust N Z J Public Health. 2008; 32 (6): 575-6.
21. Wood N, Warlow M, Quinn H, Selvey C, Lum G, McIntyre P, et al,. Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia. Aust N Z J Public Health. 2008; 32 (3): 272-5.
22. Australian Bureau of Statistics. 2001 Census of Population and Housing. Canberra (AUST): ABS; 2002.
23. Cowie BC, Kelly H,. Developing a mathematical model of hepatitis B in Australia-a new way of engaging an ancient, emergent pathogen (PP-028). Hepatol Int. 2010; 4 (1): 101.
24. HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2012. Sydney (AUST): The University of New South Wales, The Kirby Institute; 2012.
25. Cowie B, Karapanagiotidis T, Enriquez A, Kelly H,. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health. 2010; 34 (1): 72-8.
26. Hepatitis B Program, Epidemiology Unit, VIDRL. Estimated number of people living with hepatitis B virus infection in 2011. In: HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2012. Sydney (AUST): The University of New South Wales, Kirby Institute; 2012.
27. Australian Bureau of Statistics. Population Projections, Australia, 2004 to 2101. Catalogue No.: 3222.0. Canberra (AUST): ABS; 2006.
28. Department of Health and Ageing. National Health Reform Agreement. Canberra (AUST): Commonwealth of Australia; 2011 [cited 2012 Nov 26]. Available from: http://www.yourhealth.gov.au/internet/yourhealth/publishing.nsf/Content/ nhra-agreement.
29. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al,. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27 (47): 6550-7.
30. Progress Towards Meeting the 2012 Hepatitis B Control Milestone: WHO Western Pacific Region, 2011. Wkly Epidemiol Rec. 2011; 86 (19): 180-8.
31. Cowie B,. The linguistic demography of Australians living with chronic hepatitis B. Aust N Z J Public Health. 2011; 35 (1): 12-5.
32. Anikeeva O, Bi P, Hiller JE, Ryan P, Roder D, Han G-S,. The health status of migrants in Australia: a review. Asia Pac J Public Health. 2010; 22 (2): 159-93.
33. Weber MF, Banks E, Smith DP, O'Connell D, Sitas F,. Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health. 2009; 9: 144.
34. Global Hepatitis Programme. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action. Geneva (CHE): World Health Organisation; 2012.
35. Cowie B, Dore G,. The perpetual challenge of infectious diseases. N Engl J Med. 2012; 367 (1): 89-90.
36. Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, et al,. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. J Hepatol. 2009; 50 (5): 990-8.
37. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A,. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010; 53 (2): 348-56.